Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

TROPICAMIDE Drug Profile

« Back to Dashboard

Which patents cover Tropicamide, and when can generics launch?

Tropicamide is a drug marketed by Miza Pharms Usa, Akorn, Bausch And Lomb, Watson Labs, and Alcon Pharms Ltd. and is included in seven NDAs.

The generic ingredient in TROPICAMIDE is tropicamide. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the tropicamide profile page.

Summary for Tradename: TROPICAMIDE

Patents:0
Applicants:5
NDAs:7
Suppliers / Packagers: see list1
Bulk Api Vendors: see list66
Clinical Trials: see list5
Patent Applications: see list2,454
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TROPICAMIDE at DailyMed

Pharmacology for Tradename: TROPICAMIDE

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Miza Pharms Usa
TROPICAMIDE
tropicamide
SOLUTION/DROPS;OPHTHALMIC087636-001Jul 30, 1982DISCNNoNo► Subscribe► Subscribe
Alcon Pharms Ltd
TROPICAMIDE
tropicamide
SOLUTION/DROPS;OPHTHALMIC089172-001Dec 28, 1990DISCNNoNo► Subscribe► Subscribe
Bausch And Lomb
TROPICAMIDE
tropicamide
SOLUTION/DROPS;OPHTHALMIC040064-001Jul 27, 1994ATRXNoNo► Subscribe► Subscribe
Miza Pharms Usa
TROPICAMIDE
tropicamide
SOLUTION/DROPS;OPHTHALMIC087637-001Aug 9, 1982DISCNNoNo► Subscribe► Subscribe
Akorn
TROPICAMIDE
tropicamide
SOLUTION/DROPS;OPHTHALMIC088447-001Aug 28, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot